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Jakob Müller* and Michael W PfafflAbstract
Background: In traditional Chinese medicine, green tea is considered to have a life-prolonging effect, possibly as a
result of its rich content of antioxidant tea polyphenols, and hence has the potential to prevent cancer. This study
investigated the role of the major tea secondary plant compound epigallocatechin gallate (EGCG) for its inhibitory
effects on the metastasis-associated 67 kDa laminin receptor (67LR).
Methods: To clarify the impact of EGCG on siRNA-silenced expression of 67LR, we applied an adenoviral-based
intestinal in vitro knockdown model, porcine IPEC-J2 cells. Quantitative real-time polymerase chain reaction was
performed to analyze 67LR gene expression following treatment with physiological and pharmacological
concentrations of EGCG (1.0 g/l, 0.1 g/l, 0.02 g/l and 0.002 g/l).
Results: We report co-regulation of EGCG and 67LR, which is known to be an EGCG receptor. siRNA selectively and
highly significantly suppressed expression of 67LR under the impact of EGCG in a synergetic manner.
Conclusions: Our findings suggest that 67LR expression is regulated by EGCG via a negative feedback loop. The
explicit occurrence of this effect in synergy with a small RNA pathway and a plant-derived drug reveals a new
mode of action. Our findings may help to provide insights into the many unsolved health-promoting activities of
other natural pharmaceuticals.
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Studies assessing the beverage brewed from the leaves of
the tea plant Camellia sinensis and its health-promoting
effect are almost innumerable. It is assumed that among
other constituents, the major effector of ‘green’ tea is
the polyphenol epigallocatechin gallate (EGCG). One
liter of green tea in a common preparation (1 g tea/
100 ml water) contains approximately 300–1000 mg of
this secondary plant compound [1,2]. Therewith, it pro-
vides the major share of all tea catechins. The role of
green tea, and particularly EGCG, as part of a cancer-
preventive diet has been well researched [3-5].* Correspondence: jakob.mueller@wzw.tum.de
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distribution, and reproduction in any mediumMolecular targets of the green tea polyphenols are pro-
posed [6-8], but solid knowledge about the underlying
anticancer mechanisms is still missing. In 2004, a new
candidate associated with EGCG was revealed [9]: the
67 kDa laminin receptor (67LR). Tachibana et al. showed
that this protein specifically binds EGCG among other
tea catechins. Furthermore, a transmembrane signaling
pathway was postulated in which EGCG induces the ac-
tivation of myosin phosphatase through 67LR and hence
develops its anticancer potential via inhibition of cell
proliferation [10].
Indeed, in the scope of cancer research, 67LR has been
well studied [11]. It is well known that this protein is
overexpressed on the surface of cancer cells [12-15].
Thus, the involvement of 67LR in metastasis formation
has been highly investigated. During this process, antral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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by the local surface proteins. As laminin is a major com-
ponent of the basement membrane, it was shown that
enhanced expression of 67LR promotes metastasis [16].
This can be explained by the whole mechanism of the
tumor invasion process. After the attachment of the cir-
culating cancer cell, a rearrangement of the basement
membrane occurs. Thereby one determining factor is
the binding of laminin to 67LR. As a local consequence,
laminin undergoes conformational changes and can sub-
sequently be degraded by proteases [17]. Thereafter, the
tumor cell can invade the target tissue. While examining
the role of 67LR in target tissue binding during metasta-
sis it could be shown that a 67LR-derived peptide called
peptide G increases the metastatic potential in cell cul-
ture experiments [18]. Considering the fact that peptide
G represents the laminin binding site of 67LR, this
underlines the invasion model. In contrast, a synthetic
laminin pentapeptide (YIGSR) corresponding to the
binding domain of laminin was assigned as a competitive
metastasis inhibitor [19].
Taken together, it becomes clear that downregulation
of 67LR provides a gateway for metastasis prevention. In
the work of Chen et al. this basic effect has already been
demonstrated [20]. Considering the multiple clues for
the cancer-preventative effect of green tea, and regarding
the interaction of EGCG and 67LR, we focused on the
question as to whether tea catechin can influence the ex-
pression of 67LR in the gastrointestinal tract. We con-
ducted qRT-PCR expression analysis combined with an
RNAi-knockdown model to evaluate the anti-metastatic
potential of EGCG via modulation of 67LR expression




The jejunal-derived JPEC-J2 cells [21] were maintained
in Dulbecco’s modified eagle medium (DMEM)/Ham’s
F-12 (1:1) (PAA, Pasching, Austria) supplemented with
5% fetal bovine serum (FBS; PAA), 2 mM L-glutamine
(PAA) and 100 U/ml penicillin/streptomycin (PAA) at
37°C, 100% humidity and 5% CO2. This cell line was
kindly provided by Dr Karsten Tedin (FU Berlin). Only
cells that had been passaged ten times or less were used.
The cell culture assay was designed on multiwell tis-
sue culture plates (48 W) from Greiner Bio-One
(Frickenhausen, Germany) with a substrate area of 1 cm2.
In these, 5 × 104 IPEC-J2 cells were seeded in 500 μl of cell
culture media, and after 48 h of settlement the desired
knockdown treatment was applied together with fresh
media. For gene knockdown, we used adenoviral vectors
which induce siRNA expression in the target cell line in
an optimized multiplicity of infection (MOI) of 400 [22].We obtained the methodology for the gene silencing
technology from SIRION-BIOTECH (Martinsried,
Germany), with which we produced an individual
knockdown virus targeting 67LR transcript [NCBI acces-
sion number: NM_001037146], termed ‘67lr-KD’ in this
manuscript. A second targeting knockdown was designed
as a positive control, designated ‘control-KD’, and targeted
IKBKB [NCBI accession number: NM_001099935]. A
third knockdown served as negative control and repre-
sented a non-targeting virus (named ‘NV”’). The NV was
identical to the two targeting knockdown viruses
(overall named ‘TV’) but was unable to induce RNA
interference due to leakage of a siRNA-insert. This
negative control solely evoked the effects accompany-
ing viral infection. At 48 h post-infection, we treated
the cells with different concentrations (1.0 g/l, 0.1 g/l,
0.02 g/l, 0.002 g/l) of EGCG (Sigma-Aldrich St. Louis,
USA) diluted in 400 μl fresh media, following washing
with 600 μl of prewarmed PBS (pH 7.5, without Ca &
Mg; PAA). Here, EGCG treatment is abbreviated to
‘EGCG’, and the corresponding media control to
‘MEDIA’. For the assay layout, EGCG treatment and
the media control were combined with a targeting virus
or the non-targeting virus control, respectively. For
the targeting viruses, both variants (targeting 67LR and
the positive control) were applied. The resulting assay
layout consisted of the following treatment groups:
MEDIA/NV, MEDIA/TV, EGCG/NV & EGCG/TV; with
TV = 67lr-KD or control-KD. All treatment variations
were performed in triplicate (three cell culture wells).
Cells were harvested for total RNA extraction 6 h after
EGCG treatment. This included another washing step of
the cell layer with PBS, followed by direct cell lysis with
350 μl of RLT buffer (RNeasy Mini Kit, Qiagen, Hilden,
Germany). RNA was prepped according to the manufac-
turers’ instructions and then diluted to 10 ng/μl (NanoDrop
ND-1000 spectrophotometer, PEQLab Biotechnologie
GmbH, Erlangen, Germany) for subsequent gene ex-
pression analysis.
Gene expression analysis
Prior to gene expression analysis by quantitative real-
time polymerase chain reaction (qRT-PCR), the RNA
integrity was checked using a RNA nano LABchip on an
Agilent 2100 Bioanalyzer (Agilent, Santa Clara, United
States). Samples were prepared using a SuperScript III
Platinum SYBR Green One-Step qRT-PCR Kit
(Invitrogen, Karlsruhe, Germany), and analyzed using a
Corbett Rotorgene 3000 (Corbett Life Science, Sydney,
Australia). The sample volume of 10 μl contained 38 ng
RNA, 5 μl SYBR-Mix and 10 pmol primer mix (67LR
[NCBI accession number: NM_001037146], forward
primer: AGCGAGCTGTGCTGAAGTTT & reverse
primer: GTGAGCTCCCTTGTTGTTGC; IKBKB [NCBI
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GGCGAACAGAGATTAATACACAAA & reverse pri-
mer: GTGCCGAAGCTCCAGTAGTC). The cycler pro-
gram included a 10 min reverse transcription reaction at
50°C followed by a 5 min denaturation step at 95°C.
Subsequently, under continuous fluorescence measure-
ment, 40 amplification cycles (denaturation 95°C/10 s,
annealing 60°C/10 s, extension 72°C/15 s) were per-
formed, followed by a terminal melting curve measure-
ment from 40°C to 95°C (in 0.5°C steps with a lag time
of 2 sec). All qRT-PCR experiments were performed in
duplicate (two one-step qRT-PCRs). The raw data were
obtained using Rotor-Gene 6 software (Corbett Life Sci-
ence, Sydney, Australia) via the implemented compara-
tive quantification algorithm. Furthermore, the melting
curve analysis of the Rotor-Gene 6 software was
consulted for control of primer specificity. Relative
changes in gene expression (shown as percentages)
were determined under the terms of the ΔΔCq method
[23]. The Cq value displayed for the cycle number
was required by the fluorescence signal of a single
qPCR sample to cross a predefined threshold [24,25].
The chosen reference genes were Histone H3 ([NCBI
accession number: XM_003356519], forward primer:
ACTGGCTACAAAAGCCGCTC, and reverse primer:
ACTTGCCTCCTGCAAAGCAC) and GAPDH ([NCBI
accession number: XM_003358301], forward primer:
AGATCCAGGATAAGGAAGGCA, and reverse primer:
GCTCCACCTCCAGGGTGAT). All primers were gen-
erated by Eurofins MWG Operon (Ebersberg, Germany).
Statistical data evaluation
The plots visualizing gene expression indicate mean
values from repeated measurements. Thereby, the repli-
cates are specified as “n = (a) × (b) × (c)”. These variables
stand for the number of assays included (a), the cell cul-
ture replicates (b) and the qRT-PCR reactions conducted
(c). Significant changes through treatments were ascer-
tained with paired t-tests (SPSS 19.0, IBM Corporation,
Armonk, USA), and resulting P-values are indicated by
asterisks, as follows: P ≤ 0.001 = extremely significant
(***), P ≤ 0.01 = highly significant (**), P ≤ 0.05. = signifi-
cant (*), P > 0.05 = not significant (n.s.). Variations be-
tween different EGCG concentrations where tested for
significance by applying a, one-way ANOVA (SPSS 19.0,
IBM Corporation, Armonk, USA). The letters a, b, and c
indicate extremely significant intermediate variances
(P ≤ 0.001). The assay data was additionally analyzed by
principal component analysis (PCA) using GenEx soft-
ware (version 5.3.2.13, MultiD, Göteborg, Sweden).
Therefore, mean centered ΔCq values were applied [26].
PCA is a statistical visualization method for multivari-
able data sets, which reduces the dimensionality while
exposing the maximal variation embedded [27].Results and discussion
In our cell culture assays, we combined pairwise drug
treatments (EGCG vs. media control) with knockdowns
(target genes vs. control virus). Thereby, the relative
gene regulation (calculated by 2-ΔΔCq given as percent-
age relative to control) caused by a combinatory treat-
ment with target virus and/or EGCG was evaluated for
every single treatment variant in reference to its particu-
lar control group. By this method, the net knockdown
efficiency was calculated by normalizing target
knockdown-treated samples containing one individual
concentration of EGCG to the samples containing the
same EGCG concentration but that were treated with
the non-target control virus. In the same manner, the
net effect of a drug treatment becomes clear when it is
normalized within one virus treatment group to its
media control partner. Figure 1 shows the mean values
from repetitions of our cell culture assay, thereby data in
Figure 1a was offset against the knockdown controls
within one treatment (EGCG or media) variant to obtain
the net knockdown on the corresponding target gene.
The plot shows that the resulting downregulation was
approximately 90% in wells treated solely with medium
and the target virus for 67LR (MEDIA/TV, 67lr-KD)
(mean of seven independent experiments). Interestingly,
67lr-KD efficiency was altered when EGCG was applied
instead of pure media (EGCG/TV, 67lr-KD). The gene-
silenced cells that were co-treated with EGCG showed
an additional reduction in 67LR expression to result
in a knockdown efficiency of 96%. At first, the step
from 90% to 96% seems less impressive, but on
closer analysis it represents a large change. For all ex-
pression plots, the value is presented on a logarithmic
scale. Regarding the fact that relative change in
mRNA expression is calculated, a remaining transcript
level of 10% must be reduced by more than 50% to
fall down to 4%.
In follow-up measurements, we clarified if this obser-
vation originated from an artifact resulted from the
methodology applied. Therefore, we performed the assay
with another target-knockdown, which did not target
67LR (shown in Figure 1a as ‘control KD’). In this set-
ting, EGCG had no significant effect on enhancing the
knockdown efficiency, leading to the assumption that
the combination of 67LR protein and its binding partner
EGCG can promote synergetic downregulation. To dem-
onstrate the co-action between 67LR and EGCG, the
data underlying Figure 1a was adjusted to the media
control within one knockdown scenario in the plot from
Figure 1b. Thus, the extent of the synergetic effect evok-
ing 63% of relative residual 67LR mRNA expression as a
mean value from ten independent experiments was
revealed. In contrast the other treatment combinations



















MEDIA/TV normalized to MEDIA/NV - EGCG/TV normalized to EGCG/NV
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67kDa laminin receptor RNA levels (SEM, n=10x3x2)b
Figure 1 Knockdown assays comparing 67lr-KD and control-KD under EGCG treatment. a) Pooled data from seven assays normalized to
the non-targeting virus samples. This normalization revealed net knockdown effects. b) Pooled data from ten assays normalized to the media
control samples. This normalization revealed the net regulation induced by the drug treatment. (Legend: EGCG = EGCG treatment, MEDIA =media
control, NV = non-targeting virus, TV = targeting virus, 67lr-KD = 67LR knockdown, control-KD = control knockdown).
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tive expression.
To confirm our observations independent of
normalization to any control groups (virus/drug), we
consulted principal component analysis (PCA). With this
statistical data evaluation it is possible to analyze the
outcome of an assay by sample [26]. The PCA considers
the collective variation in gene expression an RNA sam-
ple bears in reference to all genes measured from it.
Therefore, our expression data were inserted in the PCA
as raw data solely corrected against the reference genes
but not against any control groups of the underlying cell
culture assay. The findings from this independent kind
of data analysis were in accordance with those from the
relative fold changes shown in Figure 1a and b. The
PCA-plot in Figure 2 shows data from an assay that also
includes eight treatment variants (MEDIA/NV, MEDIA/TV, EGCG/NV & EGCG/TV; with TV = 67lr-KD and/or
control-KD) each replicated six times (3 cell culture
wells × 2 qRT-PCR reactions). For each of these 48 data-
points (samples), the gene expression of two reference
genes and two target genes (67lr-KD, control-KD) was
ascertained. In Figure 2a, the gene expression data in-
cluding the reference genes and the control-KD gene
was analyzed. The resulting image of the PCA shows
data clustering in two clouds: (I) with (MEDIA/TV [con-
trol-KD] & EGCG/TV [control-KD]) or (II) without
(MEDIA/NV, EGCG/NV & MEDIA/TV [67lr-KD],
EGCG/TV [67lr-KD]) the considered control KD. In
contrast, the PCA considering the reference genes and
the 67LR knockdown (67lr-KD) (Figure 2b) reveals three
data clusters: (I) the 67kd-KD combined with medium
treatment (MEDIA/TV [67lr-KD]), (II) the 67kd-KD
combined with EGCG treatment (EGCG/TV [67lr-KD])
Figure 2 Principal component analysis comparing the influence of EGCG on 67LR versus the control gene. a) For the control gene, the
impact of the drug treatment was dependent on whether a gene knockdown was applied (I) or not (II). b) For the 67LR gene, siRNA-induced
downregulation altered the extent of its synergy with EGCG (I) and a new data cluster was separated from the samples solely treated with the
67lr-KD (II). When no knockdown was applied, EGCG did not affect the gene regulation (III) in accordance with Figure 3a. (Color code: black labels
indicate samples containing EGCG, grey labels indicate no EGCG; Legend: EGCG = EGCG treatment, MEDIA =media control, NV = non-targeting
virus, TV = targeting virus, 67lr-KD = 67LR knockdown, control-KD = control knockdown).
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knockdown but treated with either media or EGCG
(MEDIA/NV, EGCG/NV & MEDIA/TV [control-KD]).
Thus, the additional separation into a third cloud is
again induced exclusively under the synergy of 67lr-KD
and EGCG.
The next question was to ascertain if EGCG was able
evoke the same effect at concentrations lower than that
measured in freshly brewed green tea [1,2]. Therefore,
we added EGCG at concentrations from one (0.1 g/l) up
to three potencies (0.02 g/l & 0.002 g/l) below the actual
tea content (Figure 3). Again, we observed 67LR/EGCG
synergy, but this effect was less distinct. At an EGCG
concentration of 0.1 g/l, we observed a 3.7-fold reduc-
tion in downregulation of 67LR (Figure 3a), and at
0.02 g/l & 0.002 g/l, we were still able to measure a sig-
nificant effect (P = 0.001; Figure 3b).
Since the discovery of intra- and intercellular short
ribonucleic acids, many different species of non-coding
but functional active small RNAs have been identified
[28]. Among these, miRNAs and siRNAs are involved innegative gene regulation. However, with increasing
knowledge from in vitro studies, pathways that once ini-
tially seemed distinct have become blurred, revealing the
extent of the complexity as to how small RNAs act in
gene regulation. miRNAs were originally described to
bind the 30UTR alone, but there is now evidence that
miRNAs can also act upon the coding region of a tran-
script [29]. Within the complex machinery of posttran-
scriptional gene regulation, it has been shown that
certain miRNA signatures can serve as biomarkers for
oncology [30]. Thus, small RNA synthesis or leakage can
affect cancer and influence metastasis positively or nega-
tively depending on the targeted gene.
Our results indicate EGCG significantly influences
siRNA-induced downregulation of 67LR expression.
Since a close relation of this protein and its transcript
has been ascertained [31], these findings show a correl-
ation between the plant compound and its receptor [9]
via a negative feedback loop. Reasonably the anti meta-
static potential of green tea as a daily diet develops best
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b
Figure 3 67LR/EGCG-synergy when the secondary plant metabolite was added at potencies below the actual EGCG-content of freshly
brewed green tea. (Legend: EGCG = EGCG treatment, MEDIA =media control, NV = non-targeting virus, TV = targeting virus, 67lr-KD = 67LR
knockdown, control-KD = control knockdown).
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67LR have been associated with metastasis formation in
different tissues, including the intestine [32].
Considering our findings that EGCG acts synergistic-
ally and promotes siRNA-induced downregulation of
67LR protein, a new concept of how secondary
plant metabolites act in cancer prevention can be
established. The complex feedback control system of
miRNA regulation of oncogenes might be influenced
selectively in synergy with plant compounds, and
may provide clues to the potential anti-carcinogenic
mechanism of EGCG [2].
Conclusions
Metastasis presents the largest challenge in terms of
mortality in the treatment of cancer. In this study, we
identified a significant correlation of EGCG co-regulation with siRNA-silenced expression of 67LR in a
porcine intestinal cell line. As pigs are monogastric ani-
mals, IPEC-J2 cells represent a model conferrable to the
human gastrointestinal tract. As part of a cancer-
preventive diet, green tea may act via synergic action of
small RNA regulation and the properties of an herbal-
derived drug, EGCG.
Future tasks are represented by the assessment of the
67LR within the small RNA regulatory network of me-
tastasis models and hence the clarification of its role as
an endogenous miRNA target. Evaluating the reproduci-
bility of the shown synergic effect in other in vitro mod-
els may help to provide clues as to the mode of action of
pharmacologically-applied plant compounds.
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